{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:06:06Z","timestamp":1776053166295,"version":"3.50.1"},"reference-count":40,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2013]]},"DOI":"10.3960\/jslrt.53.29","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T23:26:52Z","timestamp":1371770812000},"page":"29-36","source":"Crossref","is-referenced-by-count":5,"title":["Simultaneous Presentation of Waldenstr^|^ouml;m Macroglobulinemia and Multiple Myeloma: Multidisciplinary Diagnosis, Treatment and 30-Month Follow-up"],"prefix":"10.3960","volume":"53","author":[{"given":"Giovanni","family":"Carulli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio M","family":"Ciancia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Azzar^|^agrave;","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Ottaviano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ciabatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Marini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Vijay A, Gertz MA: Waldenstr&ouml;m macroglobulinemia. Blood 109:5096-5103, 2007","DOI":"10.1182\/blood-2006-11-055012"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Hanzis C, Ojha RP, Hunter Z, Manning R, Lewicki M, <I>et al<\/I>.: Associated malignancies in patients with Waldenstr&ouml;m's macroglobulinemia and their kin. Clin Lymphoma Myeloma Leuk 11:88-92, 2011","DOI":"10.3816\/CLML.2011.n.016"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Fine JM, Gorin NC, Gendre JP, Petitpierre JC, Labro-Bryskier MT, <I>et al<\/I>.: Simultaneous occurrence of clinical manifestations of myeloma and Waldenstr&ouml;m's macroglobulinemia with monoclonal IgGo and IgM in a single patient. Acta Med Scand 209:229-234, 1981","DOI":"10.1111\/j.0954-6820.1981.tb11582.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Wang E, Kulbacki E, Stoecker M: Concomitant Waldenstr&ouml;m macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual. Hum Pathol 43:1135-1141, 2012","DOI":"10.1016\/j.humpath.2011.11.001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Jondeau K, Alterescu R, Franc B, Davi F, Mass&eacute; JM, <I>et al<\/I>.: Unusual evolution of Waldenstr&ouml;m's macroglobulinemia into osteolytic myeloma. Eur J Haematol 77:74-79, 2006","DOI":"10.1111\/j.1600-0609.2006.00654.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kyle RA, Rajkumar SV: Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 23:3-9, 2009","DOI":"10.1038\/leu.2008.291"},{"key":"7","unstructured":"7 Brouet JC, Fermand JP, Laurent G, Grange MJ, Chevalier A, <I>et al<\/I>.: The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients. Br J Haematol 59:55-66, 1985"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Saltman DL, Ross JA, Banks RE, Ross FM, Ford AM, <I>et al<\/I>.: Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma. Blood 74:2062-2065, 1989","DOI":"10.1182\/blood.V74.6.2062.bloodjournal7462062"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Novak PM, Mattson JC, Crisan D, Chen J, Poulik MD, <I>et al<\/I>.: Separate clones in concomitant multiple myeloma and a second B-cell neoplasm demonstrated by molecular and immunophenotypic analysis. Eur J Haematol 54:254-261, 1995","DOI":"10.1111\/j.1600-0609.1995.tb00680.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Pines A, Ben-Bassat I, Selzer G, Ramot B: Transformation of chronic lymphocytic leukemia to plasmacytoma. Cancer 54:1904-1907, 1984","DOI":"10.1002\/1097-0142(19841101)54:9<1904::AID-CNCR2820540921>3.0.CO;2-E"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yahata N, Iwase O, Iwama H, Tauchi T, Kawanishi Y, <I>et al<\/I>.: Chronic lymphocytic leukemia complicated by plasmacytoma originating from different clones. Leuk Lymphoma 39:203-207, 2000","DOI":"10.3109\/10428190009053555"},{"key":"12","unstructured":"12 Patriarca F, Gaidano G, Capello D, Zaja F, Fanin R, <I>et al<\/I>.: Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation. Haematologica 85:982-985, 2000"},{"key":"13","unstructured":"13 Zalcberg JR, Cornell FN, Ireton HJ, McGrath KM, McLachlan R, <I>et al<\/I>.: Chronic lymphatic leukemia developing in a patient with multiple myeloma: immunologic demonstration of a clonally distinct second malignancy. Cancer 50:594-597, 1982"},{"key":"14","unstructured":"14 Yakushijin Y, Sakai I, Takada K, Yasukawa M, Fujita S: Double B-cell malignancies with simultaneous onset. Rinsho Ketsueki 45:218-222, 2004 (<I>in Japanese<\/I>)"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Hayakava M, Asano T, Nakajima F, Tamai S, Nakamura H: Simultaneous presentation of malignant lymphoma of the kidney and multiple myeloma of the bone marrow. Int J Urol 5:374-376, 1998","DOI":"10.1111\/j.1442-2042.1998.tb00370.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 W&ouml;hrer S, Raderer M, Streubel B, Chott A, Drach J: Concomitant occurrence of MALT lymphoma and multiple myeloma. Ann Hematol 83:600-603, 2004","DOI":"10.1007\/s00277-004-0870-y"},{"key":"17","unstructured":"17 Wang YI, Karandikar N, Payne D, Maleki A, Schultz BA, <I>et al<\/I>.: A 3-way collision tumor of the upper respiratory tract: a composite of 2 immunophenotypically distinct mantle cell lymphomas and a plasmacytoma. Hum Pathol 39:781-787, 2008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Rawstron AC, Orfao A, Beksac M, Bezdickova L, Brooimans RA, <I>et al<\/I>.: Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 93:431-438, 2008","DOI":"10.3324\/haematol.11080"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Carulli G, Cannizzo E, Ottaviano V, Cervetti G, Buda G, <I>et al<\/I>.: Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib. Leuk Res 34:1336-1339, 2010","DOI":"10.1016\/j.leukres.2010.01.012"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Reed TJ, Reid A, Wallberg K, O'Leary TJ, Frizzera G: Determination of B-cell clonality in paraffin-embedded lymphnodes using the polymerase chain reaction. Diagn Mol Pathol 2:42-49, 1993","DOI":"10.1097\/00019606-199300020-00007"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Ritter JH, Wick MR, Adesokan PN, Fitzgibbon JF, Zhu X, <I>et al<\/I>.: Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol 108:60-68, 1997","DOI":"10.1093\/ajcp\/108.1.60"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Zwicky CS, Maddocks AB, Andersen N, Gribben JG: Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood 88:3314-3322, 1996","DOI":"10.1182\/blood.V88.9.3314.bloodjournal8893314"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Bird JM, Owen RG, D'Sa S, Snowden JA, Pratt G, <I>et al<\/I>.: Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol 154:32-75, 2011","DOI":"10.1111\/j.1365-2141.2011.08573.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kimby E, Treon SP, Anagnostopoulos A, Dimopoulos M, Garcia-Sanz R, <I>et al<\/I>.: Update on recommendations for assessing response from the Third International Workshop on Waldenstr&ouml;m's Macroglobulinemia. Clin Lymphoma Myeloma 6:380-383, 2006","DOI":"10.3816\/CLM.2006.n.013"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Pantic M, Schroettner P, Pfeifer D, Rawluk J, Denz U, <I>et al<\/I>.: Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma. Leukemia 24:885-890, 2010","DOI":"10.1038\/leu.2009.294"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Dong C, Hemminki K: Second primary neoplasms among 53159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer 85:997-1005, 2001","DOI":"10.1054\/bjoc.2001.1998"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Kaneko S, Yamaguchi N: Epidemiological analysis of site relationships of synchronous and metachronous multiple primary cancers in the National Cancer Center, Japan, 1962-1996. Jpn J Clin Oncol 29:96-105, 1999","DOI":"10.1093\/jjco\/29.2.96"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Owen RG, Barrans SL, Richards SJ, O'Connor SJ, Child JA, <I>et al<\/I>.: Waldenstr&ouml;m macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors. Am J Clin Pathol 116:420-428, 2001","DOI":"10.1309\/4LCN-JMPG-5U71-UWQB"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 McMaster ML, Caporaso N: Waldenstr&ouml;m macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. Br J Haematol 139:663-671, 2007","DOI":"10.1111\/j.1365-2141.2007.06845.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Stone MJ, Pascual V: Pathophysiology of Waldenstr&ouml;m's macroglobulinemia. Haematologica 95:359-364, 2010","DOI":"10.3324\/haematol.2009.017251"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Ciccarelli BT, Yang G, Hatjiharissi E, Ioakimidis L, Patterson CJ, <I>et al<\/I>.: Soluble CD27 is a faithful marker of disease burden and is unaffected by the rituximab-induced IgM flare, as well as by plasmapheresis, in patients with Waldenstr&ouml;m's macroglobulinemia. Clin Lymphoma Myeloma 9:56-58, 2009","DOI":"10.3816\/CLM.2009.n.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Konoplev S, Medeiros LJ, Bueso-Ramos CE, Jorgensen JL, Lin P: Immunophenotypic profile of lymphoplasmacytic lymphoma\/Waldenstr&ouml;m macroglobulinemia. Am J Clin Pathol 124:414-420, 2005","DOI":"10.1309\/3G1XDX0DVHBNVKB4"},{"key":"33","unstructured":"33 Bataille R, J&eacute;go G, Robilard N, Barill&eacute;-Nion S, Moreau P, <I>et al<\/I>.: The phenotype of normal, reactive and malignant plasma cells. Identification of &ldquo;many and multiple myelomas&rdquo; and of new targets for myeloma therapy. Haematologica 91:1234-1240, 2006"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Groves FD, Travis LB, Devesa SS, Ries LA, Fraumeni JF Jr: Waldenstr&ouml;m's macroglobulinemia: incidence patterns in the United States, 1988-1994. Cancer 82:1078-1081, 1998","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Ludwig H, Bolejack V, Crowley J, Blad&eacute; J, Miguel JS, <I>et al<\/I>.: Survival and years of life lost in different age cohorts of patients with multiple myeloma. J Clin Oncol 28:1599-1605, 2010","DOI":"10.1200\/JCO.2009.25.2114"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Ghobrial IM, Xie W, Padmanabhan S, Badros A, Rourke M, <I>et al<\/I>.: Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenstr&ouml;m macroglobulinemia. Am J Hematol 85:670-674, 2010","DOI":"10.1002\/ajh.21788"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Jagannath S, Durie BG, Wolf J, Camacho E, Irwin D, <I>et al<\/I>.: Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma. Br J Haematol 129:776-783, 2005","DOI":"10.1111\/j.1365-2141.2005.05540.x"},{"key":"38","unstructured":"38 Kumar SK, Mikhael JR, Buadi FK, Dingli D, Dispenzieri A, <I>et al<\/I>.: Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines. Mayo Clin Proc 84:1095-1110, 2009"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Morice WG, Chen D, Kurtin PJ, Hanson CA, McPhail ED: Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstr&ouml;m's macroglobulinemia. Mod Pathol 22:807-816, 2009","DOI":"10.1038\/modpathol.2009.34"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Howard MT, Hodnefield J, Morice WG: Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma\/Waldenstr&ouml;m's macroglobulinemia is comparable to flow cytometric techniques. Clin Lymphoma Myeloma Leuk 11:96-98, 2011","DOI":"10.3816\/CLML.2011.n.018"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T23:45:15Z","timestamp":1645832715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/53\/1\/53_29\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.53.29","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}